CO - Global Cord Blood Corp.: Solid Subscriber Growth Net Cash Greater Than Market Cap And High FCF Yield Of 25%

• CO is a market leader with more net cash than the market cap and our price target is $6.00 [45% upside].
• 1HFY2021 results saw total subscriber numbers grow by 10%, despite tough operating conditions.
• CO's mark-to-market gains and cost cutting efficiency saw a decent September quarter.
• Huge net cash position of 168% against the stock price.
• The global cord blood industry is expected to grow by a CAGR of 11.9% from 2016 to 2025, & Asia Pacific (with its EM) will see the highest CAGR.

For further details see: